Federal Register / Vol. 87, No. 41 / Wednesday, March 2, 2022 / Notices 11725 

may be requested in hardcopy from the 

Designated Federal Official for the BSC. 

Following the meeting, summary 

minutes will be prepared and made 

available on the BSC meeting web page. 

Meeting Attendance Registration: The 

meeting is open to the public with time 

scheduled for oral public comments. 

Registration is not required to view the 

virtual meeting; the URL for the virtual 

meeting is provided on the BSC meeting 

web page (https://ntp.niehs.nih.gov/go/ 

165) the day before the meeting. TTY 

users should contact the Federal TTY 

Relay Service at 800–877–8339. 

Requests should be made at least five 

business days in advance of the event. 

Written Public Comments: NTP 

invites written public comments. 

Guidelines for public comments are 

available at https://ntp.niehs.nih.gov/ 

ntp/about_ntp/guidelines_public_

comments_508.pdf. 

The deadline for submission of 

written comments is April 12, 2022. 

Written public comments should be 

submitted through the meeting web 

page. Persons submitting written 

comments should include name, 

affiliation, mailing address, phone, 

email, and sponsoring organization (if 

any). Written comments received in 

response to this notice will be posted on 

the NTP web page, and the submitter 

will be identified by name, affiliation, 

and sponsoring organization (if any). 

Oral Public Comment Registration: 

The agenda allows for one formal public 

comment period on the agenda topics 

(up to 5 commenters total, up to 5 

minutes per speaker per topic). Persons 

wishing to make an oral comment are 

required to register online at https://

ntp.niehs.nih.gov/go/165 by April 12, 

2022. Oral comments will be received 

only during the formal comment period 

indicated on the preliminary agenda. 

Oral comments will only be by 

teleconference line. The access number 

for the teleconference line will be 

provided to registrants by email prior to 

the meeting. Registration is on a firstcome, first-served basis. Each 

organization is allowed one time slot 

per topic. After the maximum number of 

speakers is exceeded, individuals 

registered to provide oral comment will 

be placed on a wait list and notified 

should an opening become available. 

Commenters will be notified 

approximately one week before the 

meeting about the actual time allotted 

per speaker. 

If possible, oral public commenters 

should send a copy of their slides and/ 

or statement or talking points to NTPMeetings@icf.com by April 12, 2022. 

Meeting Materials: The preliminary 

meeting agenda will be available on the 

meeting web page (https://ntp.niehs.

nih.gov/go/165) by March 14, 2022, and 

will be updated one week before the 

meeting. Individuals are encouraged to 

access the meeting web page to stay 

abreast of the most current information 

regarding the meeting. 

Background Information on the BSC: 

The BSC is a technical advisory body 

comprised of scientists from the public 

and private sectors that provides 

primary scientific oversight to the NTP. 

Specifically, the BSC advises the NTP 

on matters of scientific program content, 

both present and future, and conducts 

periodic review of the program for the 

purpose of determining and advising on 

the scientific merit of its activities and 

their overall scientific quality. Its 

members are selected from recognized 

authorities knowledgeable in fields such 

as toxicology, pharmacology, pathology, 

epidemiology, risk assessment, 

carcinogenesis, mutagenesis, cellular 

biology, computational toxicology, 

neurotoxicology, genetic toxicology, 

reproductive toxicology or teratology, 

and biostatistics. Members serve 

overlapping terms of up to four years. 

The BSC usually meets periodically. 

The authority for the BSC is provided by 

42 U.S.C. 217a, section 222 of the Public 

Health Service Act (PHS), as amended. 

The BSC is governed by the 

provisions of the Federal Advisory 

Committee Act, as amended (5 U.S.C. 

app.), which sets forth standards for the 

formation and use of advisory 

committees. 

Dated: February 24, 2022. 

Brian R. Berridge, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2022–04389 Filed 3–1–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Resource-Related 

Research Projects (R24 Clinical Trial Not 

Allowed). 

Date: March 30, 2022. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G42, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Sandip Bhattacharyya, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G42, 

Rockville, MD 20852, (240) 292–0189, 

sandip.bhattacharyya@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 24, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–04363 Filed 3–1–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Resource-Related 

Research Projects (R24 Clinical Trial Not 

Allowed). 

Date: March 25, 2022. 

Time: 1:00 p.m. to 3:00 p.m. 


lotter on DSK11XQN23PROD with NOTICES1
11726 Federal Register / Vol. 87, No. 41 / Wednesday, March 2, 2022 / Notices 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G42, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Sandip Bhattacharyya, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G42, 

Rockville, MD 20852, (240) 292–0189, 

sandip.bhattacharyya@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 24, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–04359 Filed 3–1–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

[1651–0024] 

Entry/Immediate Delivery Application 

and ACE Cargo Release 

AGENCY: U.S. Customs and Border 

Protection (CBP), Department of 

Homeland Security. 

ACTION: 30-Day notice and request for 

comments; revision of an existing 

collection of information. 

SUMMARY: The Department of Homeland 

Security, U.S. Customs and Border 

Protection will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995 (PRA). The 

information collection is published in 

the Federal Register to obtain comments 

from the public and affected agencies. 

DATES: Comments are encouraged and 

must be submitted no later than April 1, 

2022 to be assured of consideration. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional PRA information 

should be directed to Seth Renkema, 

Chief, Economic Impact Analysis 

Branch, U.S. Customs and Border 

Protection, Office of Trade, Regulations 

and Rulings, 90 K Street NE, 10th Floor, 

Washington, DC 20229–1177, 

Telephone number 202–325–0056 or via 

email CBP_PRA@cbp.dhs.gov. Please 

note that the contact information 

provided here is solely for questions 

regarding this notice. Individuals 

seeking information about other CBP 

programs should contact the CBP 

National Customer Service Center at 

877–227–5511, (TTY) 1–800–877–8339, 

or CBP website at https://www.cbp.gov/ 

. 

SUPPLEMENTARY INFORMATION: CBP 

invites the general public and other 

Federal agencies to comment on the 

proposed and/or continuing information 

collections pursuant to the Paperwork 

Reduction Act of 1995 (44 U.S.C. 3501 

et seq.). This proposed information 

collection was previously published in 

the Federal Register (Volume 86 FR 

Page 55628) on October 06, 2021, 

allowing for a 60-day comment period. 

This notice allows for an additional 30 

days for public comments. This process 

is conducted in accordance with 5 CFR 

1320.8. Written comments and 

suggestions from the public and affected 

agencies should address one or more of 

the following four points: (1) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information will have 

practical utility; (2) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

suggestions to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) suggestions to 

minimize the burden of the collection of 

information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology, e.g., permitting 

electronic submission of responses. The 

comments that are submitted will be 

summarized and included in the request 

for approval. All comments will become 

a matter of public record. 

Overview of This Information 

Collection 

Title: Entry/Immediate Delivery 

Application and ACE Cargo Release. 

OMB Number: 1651–0024. 

Form Number: CBP Forms 3461 and 

3461 ALT. 

Current Actions: Revision. 

Type of Review: Revision. 

Affected Public: Businesses. 

Abstract: All items imported into the 

United States are subject to examination 

before entering the commerce of the 

United States. There are two procedures 

available to effect the release of 

imported merchandise, including 

‘‘entry’’ pursuant to 19 U.S.C. 1484, and 

‘‘immediate delivery’’ pursuant to 19 

U.S.C. 1448(b). Under both procedures, 

CBP Forms 3461, Entry/Immediate 

Delivery, and 3461 ALT are the source 

documents in the packages presented to 

Customs and Border Protection (CBP). 

The information collected on CBP 

Forms 3461 and 3461 ALT allow CBP 

officers to verify that the information 

regarding the consignee and shipment is 

correct and that a bond is on file with 

CBP. CBP also uses these forms to close 

out the manifest and to establish the 

obligation to pay estimated duties in the 

time period prescribed by law or 

regulation. CBP Form 3461 is also a 

delivery authorization document and is 

given to the importing carrier to 

authorize the release of the 

merchandise. 

CBP Forms 3461 and 3461 ALT are 

provided for by 19 CFR 142.3, 142.16, 

141.22, and 141.24. The forms and 

instructions for Form 3461 are 

accessible at: https://www.cbp.gov/ 

newsroom/publications/forms?title=

3461&=Apply. 

Ace Cargo Release (formerly referred 

to as ‘‘Simplified Entry’’) is a program 

for ACE entry summary filers in which 

importers or brokers may file ACE Cargo 

Release data in lieu of filing the CBP 

Form 3461. This data consists of 12 

required elements: Importer of record; 

buyer name and address; buyer 

employer identification number 

(consignee number), seller name and 

address; manufacturer/supplier name 

and address; Harmonized Tariff 

Schedule 10-digit number; country of 

origin; bill of lading; house air waybill 

number; bill of lading issuer code; entry 

number; entry type; and estimated 

shipment value. The four optional data 

elements are: The container stuffing 

location, consolidator name and 

address, ship to party name and 

address, and the three Global Business 

Identifier (GBI) identifiers: (20-digit 

Legal Entity Identifier (LEI), 9-digit Data 

Universal Numbering System (DUNS), 

and 13-digit Global Location Number 

(GLN)) for the entry filer and the 

manufacturer/producer, seller and 

shipper, and optionally, for the 

exporter, distributor and packager. The 

GBI identifiers are the new optional data 

elements that are being collected to 

better identify the legal entity that is 

interacting with CBP. The data collected 

under the ACE Cargo Release program is 


lotter on DSK11XQN23PROD with NOTICES1